|
Originally published In Press as doi:10.1074/jbc.M703222200 on May 11, 2007
J. Biol. Chem., Vol. 282, Issue 27, 19321-19330, July 6, 2007
Nuclear Import of the MUC1-C Oncoprotein Is Mediated by Nucleoporin Nup62*
Yumei Leng,
Cheng Cao1,
Jian Ren,
Lei Huang,
Dongshu Chen,
Masaki Ito, and
Donald Kufe2
From the
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
The MUC1 heterodimeric transmembrane protein is aberrantly overexpressed by most human carcinomas. The MUC1 C-terminal subunit (MUC1-C) is devoid of a classical nuclear localization signal and is targeted to the nucleus by an unknown mechanism. The present results demonstrate that MUC1-C associates with importin β and not importin . The results also show that, like importin β, MUC1-C binds to Nup62 (nucleoporin p62). MUC1-C binds directly to the Nup62 central domain and indirectly to the Nup62 C-terminal -helical coiled-coil domain. We demonstrate that MUC1-C forms oligomers and that oligomerization is necessary for binding to Nup62. The MUC1-C cytoplasmic domain contains a CQC motif that when mutated to AQA abrogates oligomerization and binding to Nup62. Stable expression of MUC1 with the CQC AQA mutations was associated with targeting to the cell membrane and cytosol and attenuation of nuclear localization. The results further show that expression of MUC1(CQC-AQA) attenuates MUC1-induced (i) transcriptional coactivation, (ii) anchorage-independent growth, and (iii) tumorigenicity. These findings indicate that the MUC1-C oncoprotein is imported to the nucleus by a pathway involving Nup62.
Received for publication, April 17, 2007
* This work was supported by NCI, National Institutes of Health Grant CA97098 and United States Army Grant DAMD17-03-1-0672. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Present address: Beijing Institute of Biotechnology, Beijing 100850, China.
2 To whom correspondence should be addressed: Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115. Tel.: 617-632-3141; Fax: 617-632-2934; E-mail: donald_kufe{at}dfci.harvard.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Raina, R. Ahmad, M. D. Joshi, L. Yin, Z. Wu, T. Kawano, B. Vasir, D. Avigan, S. Kharbanda, and D. Kufe
Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells
Cancer Res.,
June 15, 2009;
69(12):
5133 - 5141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Pitroda, N. N. Khodarev, M. A. Beckett, D. W. Kufe, and R. R. Weichselbaum
From the Cover: MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment
PNAS,
April 7, 2009;
106(14):
5837 - 5841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Singh, M. E. Behrens, J. P. Eggers, R. L. Cerny, J. M. Bailey, K. Shanmugam, S. J. Gendler, E. P. Bennett, and M. A. Hollingsworth
Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
J. Biol. Chem.,
October 3, 2008;
283(40):
26985 - 26995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Carson
The Cytoplasmic Tail of MUC1: A Very Busy Place
Sci. Signal.,
July 8, 2008;
1(27):
pe35 - pe35.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|